New monoclonal antibody capable of binding integrin alpha 10 beta 1

Details for Australian Patent Application No. 2004228605 (hide)

Owner Xintela AB

Inventors Lundgren-Akerlund, Evy

Agent Davies Collison Cave

Pub. Number AU-B-2004228605

PCT Pub. Number WO2004/089990

Priority 60/320,112 16.04.03 US; 0301087-3 14.04.03 SE

Filing date 14 April 2004

Wipo publication date 21 October 2004

Acceptance publication date 26 May 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

G01N 33/566 (2006.01) Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

Event Publications

27 October 2005 PCT application entered the National Phase

  PCT publication WO2004/089990 Priority application(s): WO2004/089990

10 April 2008 Assignment before Grant

  Cartela AB The application has been assigned to Cartela R&D

13 November 2008 Alteration of Name

  The name of the applicant has been altered to Cartela R & D AB

29 July 2010 Assignment before Grant

  Cartela R & D AB The application has been assigned to Xintela AB

26 May 2011 Application Accepted

  Published as AU-B-2004228605

22 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004228607-Process for the preparation of amorphous calcium salt of atorvastatin

2004228602-New non-ionic surfactants for solubilizing poorly soluble molecules